0001497504 PLx Pharma Inc. false --12-31 Q3 2022 0.001 0.001 12,642,000 12,642,000 45,000 45,000 12,642 12,642 12,642 12,642 0.00...
- Significant Reduction in Operating Expenses - Strategic Alternatives Process Ongoing Total Net Sales of $0.4...
SPARTA, N.J., Oct. 26, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a...
0001497504 false 0001497504 2022-10-07 2022-10-07 iso4217:USD xbrli:shares...
SPARTA, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Madrigal Pharmaceuticals (MDGL – Research Report...
0001497504 false 0001497504 2022-08-12 2022-08-12 iso4217:USD xbrli:shares...
Results of National Patient Experience Survey Show 95% Satisfaction Rate with VAZALORE 81 mg as Aspirin Therapy...
- Initiates Evaluation of Strategic Alternatives to Enhance Stockholder Value - Reports Positive Results of...
SPARTA, N.J., July 27, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a...
SPARTA, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a...
SPARTA, N. J., May 20, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a...
Raymond James analyst Elliot Wilbur maintained a Buy rating on PLx Pharma (PLXP – Research Report) today and set a price target of $10.00. The...
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cyclacel Pharmaceuticals (CYCC – Research Report...
0001497504 false 0001497504 2022-05-13 2022-05-13 iso4217:USD xbrli:shares...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.